SCHEMBL6783768

SCHEMBL6783768

COc1ccc(C(=O)N(Cc2ccccc2-c2ccccc2)c2ccccc2)cc1OC

nearest known ligand 0.51

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ LPAR1 Q92633 2/20 0.51
▸ ACHE P22303 4/20 0.46
▸ BCHE P06276 3/20 0.46
▸ PTGES O14684 1/20 0.45
▸ ALOX5 P09917 1/20 0.45
▸ TSHR P16473 1/20 0.45
▸ MCHR1 Q99705 1/20 0.44
▸ CA12 O43570 1/20 0.43
▸ CA1 P00915 1/20 0.43
▸ CA2 P00918 1/20 0.43
▸ CA4 P22748 1/20 0.43
▸ CA6 P23280 1/20 0.43
▸ CA7 P43166 1/20 0.43
▸ TPMT P51580 1/20 0.43
▸ CA9 Q16790 1/20 0.43
▸ CA14 Q9ULX7 1/20 0.43
▸ ELANE P08246 1/20 0.43
▸ MAPK1 P28482 1/20 0.43
▸ SMN1; SMN2 Q16637 1/20 0.43
▸ REN P00797 1/20 0.43

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6778886 0.82 MCHR1 (0.43) LPAR1PTGESALOX5TSHRMCHR1
SCHEMBL6778364 0.82 PTGES (0.56) LPAR1PTGESALOX5TSHRLTB4R2
SCHEMBL31447661 0.81 PTGES (0.50) LPAR1ACHEBCHEPTGESALOX5
SCHEMBL6780194 0.79 NPC1 (0.64) ACHEBCHEPTGESALOX5
SCHEMBL6774383 0.78 LMNA (0.53) LPAR1ACHEBCHEPTGESALOX5
SCHEMBL6774704 0.78 TSHR (0.47) LPAR1TSHRMCHR1SMN1; SMN2LTB4R2
SCHEMBL6775052 0.77 HTT (0.49) LPAR1MAPK1
SCHEMBL6773978 0.77 ALDH1A1 (0.53) PTGESALOX5SMN1; SMN2
SCHEMBL6781113 0.77 PTGES (0.60) ACHEBCHEPTGESALOX5TSHR
SCHEMBL6778401 0.77 PTGES (0.67) ACHEBCHEPTGESALOX5TSHR

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20020156281-A1 Amide inhibitors of microsomal triglyceride transfer protein BOOTH RICHARD JOHN (US) 2002-10-24 — — US claimed
US-6780883-B2 ANTICHOLESTEROL AGENTS; CARDIOVASCULAR DISORDERS; ANTILIPEMIC AGENTS; RESTENOSIS; DIETETICS WARNER-LAMBERT COMPANY 2004-08-24 — — US disclosed
US-20020156281-A1 Amide inhibitors of microsomal triglyceride transfer protein BOOTH RICHARD JOHN (US) 2002-10-24 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20020156281-A1 Amide inhibitors of microsomal triglyceride transfer protein CETP, MTTP, LCAT LPAR1 2233/4885ACHE 3888/4885BCHE 2223/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback